SCHEMBL2108510

SCHEMBL2108510

CCCCCCCC(C)(O)CC

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FDPS P14324 10/20 0.46
GGPS1 O95749 7/20 0.46
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
SMPD1 P17405 1/20 0.42
CES2 O00748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101337 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL26106036 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL30987411 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL6322448 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL6327462 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL2107843 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL2108259 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL5049904 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL308714 1.00 FDPS (0.46) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL295624 0.97 FDPS (0.44) FDPSGGPS1TSHRTHRBSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558903-B1 PROCESS FOR PHOSPHORYLATING A COMPLEX ALCOHOL AVECHO BIOTECHNOLOGY LTD (AU) 2024-07-03 EP disclosed
CN-118256310-A Cleaning agent for supercritical fluid processing apparatus and cleaning method for supercritical fluid processing apparatus using same YKK株式会社 2024-06-28 CN disclosed
US-11753435-B2 Process AVECHO BIOTECHNOLOGY LIMITED (AU) 2023-09-12 US disclosed
US-20220106353-A1 PROCESS AVECHO BIOTECHNOLOGY LIMITED (AU) 2022-04-07 US disclosed
CN-110662733-A Method of producing a composite material 埃维科生物技术有限公司 2020-01-07 CN disclosed
US-20190330260-A1 PROCESS AVECHO BIOTECHNOLOGY LIMITED (AU) 2019-10-31 US disclosed
EP-3558903-A1 PROCESS Avecho Biotechnology Limited (AU) 2019-10-30 EP disclosed
WO-2018112512-A1 PROCESS PHOSPHAGENICS LIMITED (AU) 2018-06-28 WO disclosed
US-8158088-B2 Extractant compositions for co-extracting cesium and strontium, a method of separating cesium and strontium from an aqueous feed, and calixarene compounds BATTELLE ENERGY ALLIANCE, LLC (US) 2012-04-17 US disclosed
US-20100116749-A1 EXTRACTANT COMPOSITIONS FOR CO EXTRACTING CESIUM AND STRONTIUM, A METHOD OF SEPARATING CESIUM AND STRONTIUM FROM AN AQUEOUS FEED, CALIXARENE COMPOUNDS, AND AN ALCOHOL MODIFIER UT-BATTELLE, LLC 2010-05-13 US disclosed
EP-1922398-A1 CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-05-21 EP disclosed
WO-2007028477-A1 CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100116749-A1 EXTRACTANT COMPOSITIONS FOR CO EXTRACTING CESIUM AND STRONTIUM, A METHOD OF SEPARATING CESIUM AND STRONTIUM FROM AN AQUEOUS FEED, CALIXARENE COMPOUNDS, AND AN ALCOHOL MODIFIER CANX, CBX6, CALD1 FDPS 4564/4885GGPS1 4828/4885TSHR 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.